United States Antimony Corporation Reports First Quarter 2026 Financial and Operating Results
Rhea-AI Summary
United States Antimony (NYSE:UAMY) reported Q1 2026 revenue of $6.8 million and a net loss of $11.3 million ($0.08 per diluted share). The company achieved $12.8 million in Department of War grant milestones, acquired the $4.8 million Radersburg mill, raised $48.6 million post‑quarter, and reiterated 2026 gross revenue guidance of $125 million.
AI-generated analysis. Not financial advice.
Positive
- Received $12.8 million of a $27 million DoW grant for Thompson Falls expansion
- Completed first two delivery notices under $245 million DLA antimony contract
- Raised $48.6 million gross via 4.2 million share issuance post‑quarter
- Pro forma liquidity of $108.7 million, including cash, Treasuries and Larvotto securities
- Acquired Radersburg flotation mill for $4.8 million, advancing vertical integration
- Thompson Falls smelter expansion nearing completion, expected online within weeks
- Antimony average sales price per pound up 22% to $19.92
- Antimony inventory value increased to $21.7 million from $12.0 million at year‑end 2025
- Hydrometallurgical JV with Americas Gold and Silver; company holds 49% and is managing member
- Fostung project TRS shows 54 million pounds WO₃ and up to $4.6 billion future revenue potential
- Larvotto equity investment value rose to $46.6 million as of May 13, 2026
Negative
- Q1 2026 revenue $6.8 million versus $7.0 million in Q1 2025
- Gross margin declined to 16% from 34% year over year
- Recorded $7.5 million operating loss versus prior‑year operating income of $0.4 million
- Net loss of $11.3 million versus net income of $0.6 million in Q1 2025
- Operating expenses rose to $8.6 million, including $4.8 million in share‑based compensation
- Cash and Treasuries decreased to $23.7 million from higher levels at December 31, 2025
- Approximately 4.2 million new shares issued post‑quarter, implying shareholder dilution
- No Q1 2026 revenue recognized yet under the existing DLA contract
News Market Reaction – UAMY
On the day this news was published, UAMY declined 10.03%, reflecting a significant negative market reaction. Argus tracked a trough of -11.0% from its starting point during tracking. Our momentum scanner triggered 38 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $153M from the company's valuation, bringing the market cap to $1.37B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
UAMY fell 5.05% while key peers showed mixed moves: CRML +3.11%, NEXA +7.81%, but LAR, SGML, and SLI declined -6%, -9.12%, and -5.34% respectively, pointing to stock-specific pressure.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 05 | Earnings webcast notice | Positive | +13.1% | Announced timing and details for Q1 2026 earnings release and webcast. |
| Mar 19 | FY 2025 results | Positive | -10.4% | Reported strong FY 2025 revenue and gross profit growth with reiterated 2026 guidance. |
| Nov 12 | Q3 2025 results | Positive | -5.6% | Showed large year-over-year revenue and margin gains plus narrowed 2025 guidance. |
| Aug 12 | Q2 2025 results | Positive | +5.0% | Highlighted strong Q2/H1 2025 revenue growth, margin expansion, and net income turnaround. |
| May 08 | Q1 2025 results | Positive | -7.1% | Reported record Q1 2025 revenue, higher gross profit, and Montana smelter expansion plans. |
Earnings and related updates have often seen mixed reactions, with several fundamentally strong reports followed by negative price moves, indicating a history of divergence between operating progress and short-term trading.
Over the past year, UAMY has reported rapid growth, with fiscal 2025 revenues up 163% to $39.26M and gross profit up 185% to $9.87M, while reiterating 2026 gross revenue guidance of $125M. Earlier earnings showed record Q1 2025 revenue of $7M and improving margins, but also net losses tied to non-cash items and heavy capital investment. Today’s Q1 2026 report, with a $11.3M net loss and reiterated $125M guidance, continues that pattern of aggressive build-out alongside uneven near-term profitability.
Historical Comparison
Past earnings-related releases saw an average move of -1.03%. Today’s -5.05% reaction represents a larger-than-usual downside response versus prior earnings updates.
Earnings updates trace a trajectory from record Q1 2025 growth, through strong FY 2025 results and reiterated $125M 2026 guidance, to Q1 2026 where the company emphasizes heavy investment, government-backed projects, and the same 2026 revenue target.
Market Pulse Summary
The stock dropped -10.0% in the session following this news. A negative reaction despite reiterated $125M 2026 revenue guidance fits a pattern where strong operational updates sometimes met selling pressure. Q1 2026 shows a $11.3M net loss, gross margin at about 16%, and higher operating expenses tied to expansion, which can weigh on sentiment. At the same time, the company secured $12.8M in grant milestones and raised $48.6M of equity, so future trading often hinged on delivering against these growth investments.
Key Terms
defense production act regulatory
government grants (topic 832) financial
held-to-maturity u.s. treasury securities financial
technical report summary ("trs") regulatory
inferred mineral resources technical
subpart 1300 of regulation s‑k regulatory
grant receivable financial
construction in progress financial
AI-generated analysis. Not financial advice.
Received
First Two Delivery Notices under the
Q1 2026 Revenues of
Post-Quarter Equity Issuances Generated
Reiterates Full-Year 2026 Gross Revenue Guidance of
"The Critical Minerals and ZEO Company"
~ Antimony, Cobalt, Gold, Tungsten, and Zeolite ~
DALLAS, TX / ACCESS Newswire / May 14, 2026 / United States Antimony Corporation ("USAC," "US Antimony Corporation," or the "Company") (NYSE:UAMY)(NYSE Texas:UAMY), a leading producer and processor of antimony, zeolite, and other critical minerals, and the only fully integrated antimony company in the world outside of China and Russia, today reported its financial and operating results for the first quarter ended March 31, 2026.
First Quarter 2026 Highlights
Revenues of
$6.8 million , compared to$7.0 million in Q1 2025Gross profit of
$1.1 million (16% gross margin), compared to$2.4 million (34% gross margin) in Q1 2025Operating loss of
$7.5 million , compared to operating income of$0.4 million in Q1 2025Net loss of
$11.3 million , including$9.3 million of net non-cash items, compared to net income of$0.6 million in Q1 2025Achieved
$12.8 million (out of$27 Million ) in Department of War ("DoW") grant milestones at the Thompson Falls expansion project, recognized as a grant receivable with a corresponding reduction to construction in progress (PP&E)Acquired the Radersburg flotation mill in Montana for
$4.8 million , further advancing the Company's vertical integration strategyCash and cash equivalents, including held-to-maturity U.S. Treasury securities of
$23.7 million at quarter-end; Subsequent to quarter-end, the Company raised approximately$48.6 million of gross proceeds through the issuance of approximately 4.2 million shares of common stock at an average price of$11.57 per share. Total liquidity, pro forma for the post March 31, 2026 stock issuances is$108.7 million , including cash, U.S. Treasury securities and our Larvotto Resources Limited (ASX: LRV) marketable securities discussed subsequently in this release.Reiterating full-year 2026 gross revenue guidance of
$125 million
Strategic Overview
During the first quarter of 2026, the Company continued to advance its strategy to build a fully integrated critical minerals platform supporting U.S. national security and supply chain resiliency. Key accomplishments during the quarter included the achievement of milestones under the Company's DoW grant program, the acquisition of the Radersburg flotation mill, first delivery notice to the DLA under the
First Quarter 2026 Financial Results
Revenues for the first quarter of 2026 were
Cost of revenues increased to
Zeolite revenue was
The Company's current antimony inventory is a combination sourced from international third-party suppliers as well as mined from the Company's owned Stibnite Hill, Montana mining claims. The value of our antimony inventory is approximately
Operating expenses were
The Company recorded an operating loss of
Liquidity, Capital Resources, and Subsequent Events
At March 31, 2026, the Company had cash and cash equivalents and investments in held-to-maturity U.S. Treasury securities totaling liquid resources of
Subsequent to March 31, 2026 and through the date of this release, the Company sold approximately 4.2 million shares of common stock at an average price of approximately
In addition, the Company holds an investment in publicly traded equity securities (Larvotto Resources Limited ( with a quarter-end fair value of USD
Capital Expenditures and Department of Defense Grant
Capital expenditures during the first quarter of 2026 totaled
During the first quarter, the Company achieved milestones under its Defense Production Act grant award from the DoW, resulting in formal approval by the Defense Industrial Base Consortium for the completion of three project milestones representing
Operating and Strategic Updates
During and subsequent to the first quarter, the Company made progress across its critical minerals platform:
Thompson Falls Expansion: The Company's smelter expansion at Thompson Falls, Montana is nearing completion and is expected to come online over the next few weeks, significantly increasing domestic antimony processing capacity, not only for the Company, but for the country.
Radersburg Flotation Mill: The Company acquired the Radersburg flotation and concentration facility in Montana for
$4.8 million , supporting vertical integration of the Company's antimony processing operations. A new critical minerals testing laboratory has recently been installed. Now that this asset is100% owned, no prior lease payments incurred for a similar facility will be incurred.Hydrometallurgical Joint Venture: The Company entered into a joint venture agreement with Americas Gold and Silver Corporation ("Americas") as announced on February 10, 2026 (see press release of same date) to construct and operate a new, state-of-the-art hydrometallurgical processing facility. The joint venture will be owned
51% by Americas and49% by the Company, with the Company serving as managing member. Under the terms of the agreement, Americas will contribute the project site and existing infrastructure, along with feedstock, while the Company will contribute its proprietary North America hydrometallurgical processing technology and technical expertise. Capital contributions for the facility's construction are expected to be funded pro-rata based on ownership interests, unless otherwise agreed. Primary site-level environmental and operating permits have been obtained, while certain construction permits are pending. An application for funding the cost of construction of the project has been made to the DoW.DLA Contract: The Company has received approximately
$12 million in sales orders under its existing contract with the U.S. DLA. No revenue under this contract was recognized during Q1 2026. Additionally, the first and second delivery notices of finished product (antimony ingots) have been given to the DoW.On April 10, 2026 (see announcement of same date), the Company provided an operational update on its
100% owned Fostung Project, an intermediate-stage tungsten exploration asset located in Sudbury District, Ontario by making available its Technical Report Summary ("TRS") on the property, which disclosed Inferred Mineral Resources of approximately 14.7 million tons at0.17% WO₃, containing approximately 54 million pounds of tungsten trioxide and future resource revenue potential of up to$4.6 Billion over the life of the property based on the assumptions in the TRS.
2026 Outlook
The Company is reiterating its full-year 2026 gross revenue guidance of approximately
Management Commentary
Commenting on the first quarter 2026 results, Mr. Gary C. Evans, Chairman and Chief Executive Officer of US Antimony Corporation, stated: "When you are building a vertical business at the speed we are achieving at USAC, things rarely move in a straight line. There will be bumps in the road. Our first quarter results reflect a deliberate investment phase for our future. I told the 'street' during our year-end conference call that our total operating results were likely to be 'bumpy' this year. The increase in operating expense, the inventory build, and the capital expenditures we made in the quarter are the necessary foundation for the production scale-up we expect during the balance of 2026. While these investments drove a near-term loss, primarily all non-cash related, we believe we are much better positioned for the Company to deliver materially stronger financial performance in future reporting periods as our Montana-based mining, processing, and expanded smelting capabilities come online and integrate with our own material over the course of the year."
Mr. Evans continued: "We are particularly pleased with the progress under our DoW grant program, the addition of the Radersburg flotation mill, and the formation of our hydrometallurgical joint venture, each of which advances the vertical integration of our critical minerals platform. While government grant requests are never guaranteed, we believe our three official filings made since the first of this year, which total
Conference Call Details
US Antimony management will host a conference call on Thursday, May 14, 2026 at 4:15 p.m. Eastern time to discuss its first quarter 2026 financial and operating results, followed by a question-and-answer period.
Date: Thursday, May 14, 2026
Time: 4:15 p.m. Eastern time
Toll-free dial-in: 888-506-0062
International dial-in: 973-528-0011
Participant access code: 130357
Webcast URL: https://www.webcaster5.com/Webcast/Page/2604/53986
A replay of the conference call and the transcript will be available in the Investors section of the Company's website at https://www.usantimony.com/investors.
About United States Antimony Corporation
United States Antimony Corporation and its subsidiaries in the U.S., Mexico, and Canada ("USAC," "U.S. Antimony," the "Company," "Our," "Us," or "We") sell antimony, zeolite, and precious metals primarily in the U.S., Mexico, and Canada. The Company mines, purchases, and processes ore primarily into antimony oxide, antimony metal, antimony trisulfide, and precious metals at its facilities located in Montana and Mexico. Antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Antimony metal is used in bearings, storage batteries, and ordnance. Antimony trisulfide is used as a primer in ammunition. The Company also recovers precious metals, primarily gold and silver, at its Montana facility from third-party ore. At its Bear River Zeolite ("BRZ") facility located in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, soil amendment and fertilizer, and other miscellaneous applications. From 2024 through 2026, the Company has acquired mining claims, real properties (patented claims), and leases located in Alaska, Montana, and Ontario, Canada - including the Radersburg flotation mill acquired in the first quarter of 2026 - to reduce the cost of third-party antimony ore purchases and to expand its product offerings.
Learn more about United States Antimony Corporation at www.usantimony.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the Company's full-year 2026 revenue guidance, the expected commissioning of the Thompson Falls smelter expansion, the expected development and contribution of the Fostung Tungsten project, the expected timing and contribution of shipments under the DLA contract, the expected impact of in-house ore processing on margins, the recognition and continuation of funding under the DoW grant program, the expected use of post-quarter equity issuance proceeds, the application of new accounting pronouncements (including ASU 2025-10), and other statements that are not historical facts. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which the Company operates, as well as management's beliefs and assumptions. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," "should," "could," and variations of these words or similar expressions are intended to identify such forward-looking statements.
Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in such statements, including, but not limited to: fluctuations in the market prices and demand for antimony and zeolite; changes in domestic and global economic conditions; operational risks inherent in mining and mineral processing; geological or metallurgical conditions; availability and cost of energy, equipment, transportation, and labor; the Company's ability to maintain or obtain permits, licenses, and regulatory approvals; changes in environmental and mining laws or regulations; competitive factors; the impact of geopolitical developments; and the effects of weather, natural disasters, or health pandemics on operations and supply chains. Additional information regarding risk factors that could cause actual results to differ materially is included in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
Contacts
Investor Relations Contact: Jonathan Miller, VP, Investor Relations | Media Relations Contact: Anthony D. Andora |
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Three months ended March 31, | ||||||||
2026 | 2025 | |||||||
|
| |||||||
Revenues | $ | 6,784,069 | $ | 7,000,005 | ||||
Cost of revenues | 5,674,602 | 4,628,275 | ||||||
Gross profit | 1,109,467 | 2,371,730 | ||||||
Operating expenses: | ||||||||
General and administrative | 1,331,969 | 550,595 | ||||||
Salaries and benefits | 5,879,794 | 1,000,555 | ||||||
Professional fees | 1,281,131 | 382,036 | ||||||
Gain on sale or disposal of property, plant and equipment, net | (1,900 | ) | (500 | ) | ||||
Other operating expenses | 135,668 | 81,052 | ||||||
Total operating expenses | 8,626,662 | 2,013,738 | ||||||
Income (loss) from operations | (7,517,195 | ) | 357,992 | |||||
Other income (expense), net: | ||||||||
Interest and investment income | 328,288 | 192,156 | ||||||
Unrealized loss on investment in equity securities | (4,061,430 | ) | - | |||||
Other miscellaneous expense, net | (28,027 | ) | (3,624 | ) | ||||
Total other income (expense), net | (3,761,169 | ) | 188,532 | |||||
Income (loss) before income taxes and equity in loss of joint venture | (11,278,364 | ) | 546,524 | |||||
Income tax expense | - | - | ||||||
Income (loss) before equity in losses of joint venture | (11,278,364 | ) | 546,524 | |||||
Equity in losses of joint venture | (16,126 | ) | - | |||||
Net income (loss) | (11,294,490 | ) | 546,524 | |||||
Preferred dividends | (1,875 | ) | (1,875 | ) | ||||
Net income (loss) available to common shareholders | $ | (11,296,365 | ) | $ | 544,649 | |||
Net income (loss) per share: | ||||||||
Basic | $ | (0.08 | ) | $nil | ||||
Diluted | $ | (0.08 | ) | $nil | ||||
Weighted average shares outstanding: | ||||||||
Basic | 141,612,253 | 113,703,415 | ||||||
Diluted | 141,612,253 | 122,394,861 | ||||||
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
March 31, 2026 | December 31, 2025 | |||||||
ASSETS |
|
| ||||||
CURRENT ASSETS |
|
| ||||||
Cash and cash equivalents | $ | 3,220,400 | $ | 30,494,320 | ||||
Investment in debt securities held to maturity | 4,620,170 | 4,577,706 | ||||||
Accounts receivable, net | 2,512,957 | 4,213,305 | ||||||
Government grant receivable | 12,848,246 | - | ||||||
Inventories | 22,026,820 | 12,522,009 | ||||||
Prepaid expenses and other current assets | 734,552 | 434,842 | ||||||
Note receivable | 2,445,762 | 2,500,000 | ||||||
Total current assets | 48,408,907 | 54,742,182 | ||||||
Property, plant and equipment, net | 46,668,672 | 42,374,839 | ||||||
Operating lease right-of-use assets | 38,223 | 48,106 | ||||||
Investment in debt securities held to maturity - noncurrent | 15,922,926 | 15,773,251 | ||||||
Investment in equity securities | 36,432,898 | 40,494,328 | ||||||
Investment in joint venture | 83,874 | - | ||||||
Restricted cash for reclamation bonds | 163,778 | 162,756 | ||||||
Other assets, net | 330,207 | 330,207 | ||||||
Total assets | $ | 148,049,485 | $ | 153,925,669 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
CURRENT LIABILITIES | ||||||||
Accounts payable | $ | 9,672,375 | $ | 6,924,518 | ||||
Accrued liabilities | 3,388,210 | 2,937,842 | ||||||
Accrued liabilities - directors | 140,958 | 143,931 | ||||||
Current portion of operating lease liabilities | 27,477 | 34,103 | ||||||
Current portion of long-term debt | 138,140 | 136,942 | ||||||
Total current liabilities | 13,367,160 | 10,177,336 | ||||||
Operating lease liabilities, net of current portion | 10,746 | 14,003 | ||||||
Long-term debt, net of current portion | 23,495 | 58,483 | ||||||
Asset retirement obligations | 2,753,172 | 2,720,658 | ||||||
Total liabilities | 16,154,573 | 12,970,480 | ||||||
COMMITMENTS AND CONTINGENCIES (Note 5,9,15) | ||||||||
STOCKHOLDERS' EQUITY | ||||||||
Preferred stock | ||||||||
Series A - no shares issued and outstanding | - | - | ||||||
Series B - 750,000 shares issued and outstanding (liquidation preference | 7,500 | 7,500 | ||||||
Series C - 177,904 shares issued and outstanding (liquidation preference | 1,779 | 1,779 | ||||||
Series D - no shares issued and outstanding | - | - | ||||||
Common stock, | 1,437,390 | 1,400,423 | ||||||
Treasury stock (699,605 and 149,639 shares of common stock at cost, respectively) | (6,372,556 | ) | (574,153 | ) | ||||
Additional paid-in capital | 193,603,838 | 185,608,189 | ||||||
Accumulated deficit | (56,783,039 | ) | (45,488,549 | ) | ||||
Total stockholders' equity | 131,894,912 | 140,955,189 | ||||||
Total liabilities and stockholders' equity | $ | 148,049,485 | $ | 153,925,669 | ||||
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
Three months ended March 31, | ||||||||
2026 | 2025 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
| ||||||
Net income (loss) | $ | (11,294,490 | ) | $ | 546,524 | |||
Adjustments to reconcile income (loss) to net cash (used in) provided by operating activities: | ||||||||
Depreciation and amortization | 410,459 | 281,970 | ||||||
Accretion of asset retirement obligation | 32,514 | 19,483 | ||||||
Noncash operating lease expense | - | 146,962 | ||||||
Share-based compensation | 4,833,965 | 245,384 | ||||||
Accretion income from investment securities held to maturity | (192,139 | ) | - | |||||
Paid-in-kind interest from notes receivable | (45,762 | ) | - | |||||
Gain on sale or disposal of property, plant and equipment, net | (1,900 | ) | (500 | ) | ||||
Equity in losses of joint venture | 16,126 | - | ||||||
Write-down of inventory to net realizable value | 161,456 | - | ||||||
Change in allowance for credit losses | 156 | - | ||||||
Unrealized loss on investment in equity securities | 4,061,430 | - | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | 1,700,192 | (816,722 | ) | |||||
Inventories | (9,666,267 | ) | (2,745,387 | ) | ||||
Prepaid expenses and other current assets | (299,710 | ) | (23,428 | ) | ||||
IVA receivable and other assets | - | (267,993 | ) | |||||
Accounts payable | (2,223,094 | ) | 1,660,372 | |||||
Accrued liabilities | 450,368 | (757,919 | ) | |||||
Accrued liabilities - directors | (2,973 | ) | (18,037 | ) | ||||
Net cash used in operating activities | (12,059,669 | ) | (1,729,291 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Investment in joint venture | (100,000 | ) | - | |||||
Proceeds from notes receivable principal payment | 100,000 | - | ||||||
Proceeds from sales of property, plant and equipment | 1,900 | 500 | ||||||
Purchases of property, plant and equipment | (12,581,587 | ) | (862,511 | ) | ||||
Net cash used in investing activities | (12,579,687 | ) | (862,011 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Principal payments on long-term debt | (33,790 | ) | (32,632 | ) | ||||
Proceeds from exercises of stock options | 48,624 | - | ||||||
Treasury stock acquired | (4,982,634 | ) | - | |||||
Proceeds from issuance of common stock, net of issuance costs | 1,339,446 | 2,392,317 | ||||||
Proceeds from exercise of warrants | 994,812 | 806,438 | ||||||
Net cash (used in) provided by financing activities | (2,633,542 | ) | 3,166,123 | |||||
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | (27,272,898 | ) | 574,821 | |||||
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD | 30,657,076 | 18,270,898 | ||||||
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD | $ | 3,384,178 | $ | 18,845,719 | ||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||||||
Interest paid in cash | $ | 1,699 | $ | 2,937 | ||||
NON-CASH FINANCING AND INVESTING ACTIVITIES: | ||||||||
Recognition of operating lease liability and right-of-use asset | $ | - | $ | 63,416 | ||||
Property and equipment included in accounts payable | $ | 4,970,951 | $ | - | ||||
SOURCE: United States Antimony Corp.
View the original press release on ACCESS Newswire